Studies on cerebral protection of digoxin against ischemia/reperfusion injury in mice

Yakugaku Zasshi

Volumn 129, Issue 4, 2009, Pages 435-443

  Kaur, Shaminder ^a   Rehni, Ashish K ^b   Singh, Nirmal ^a   JAGGi, Amteshwar S ^a  

^a PUNJABI UNIVERSITY   (India)

^b CHITKARA UNIVERSITY   (India)

Author keywords

3,4 dichlorobenzamil; Cerebral ischemia; Digoxin; Na+ Ca2+ exchanger; Pharmacological preconditioning; Ruthenium red; Verapamil

Indexed keywords

3,4 DICHLOROBENZAMIL; CALCIUM; DIGOXIN; RUTHENIUM RED; SODIUM CALCIUM EXCHANGE PROTEIN; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; VERAPAMIL; 3',4' DICHLOROBENZAMIL; 3',4'-DICHLOROBENZAMIL; AMILORIDE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM CELL LEVEL; CAROTID ARTERY OBSTRUCTION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOTOR COORDINATION; MOUSE; NEUROPROTECTION; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STAINING; SWISS WEBSTER MOUSE; WALKING; ANIMAL; BRAIN; CALCIUM SIGNALING; DRUG ANTAGONISM; METABOLISM; PSYCHOMOTOR PERFORMANCE;

AMILORIDE; ANIMALS; BRAIN; BRAIN ISCHEMIA; CALCIUM; CALCIUM SIGNALING; DIGOXIN; MALE; MEMORY; MICE; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR PERFORMANCE; REPERFUSION INJURY; RUTHENIUM RED; VERAPAMIL;

EID: 66149147525     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.435     Document Type: Article

References (46)

1. Murray C.-E., Jennings R.-B., Reimer K. A., Circulation, 74, 1124-1136 (1986).
2. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., Brain Res., 528, 21-24 (1990).
3. Lee H.-T., Emala C.-W., Am.J.Physiol. Renal Physiol., 278, F380-F387 (2000).
4. Ferencz A., Racz B., Gasz B., Benko L., Jan- cso G., Kurthy M., Roth E., Microsurgery, 26(1), 54-57 (2006).
5. Mounsey R.-A., Pang C.-Y., Boyd J.-B., Forrest C., J. Otolaryngol., 21(5), 315-320 (1992).
6. Fung J.-J., Liver Transpl., 7(4), 300-301 (2001).
7. Matsuyama K., Chiba Y., Ihaya A., Kimura T., Tanigawa N., Muraoka R., Ann. Thorac. Surg., 63, 1315-1320 (1997).
8. McCormick P.-H., Chen G., Tlerney S., Kelly C.-J., Bouchier-Hayes D.-J., J. Surg. Res., 109(1), 24-30 (2003).
9. Rehni A.-K., Shri R., Singh M., Indian J. Exp. Biol., 45, 247-252 (2007).
10. Rehni A.-K., Singh N., Pharmacol. Rep., 59, 197-203 (2007).
11. Rehni A.-K., Singh N., Singh A.-S., Yakugaku Zasshi, 127, 1013-1020 (2007).
12. Rehni A.-K., Bhateja P., Singh N., Jaggi A.- S., Fundamental Clin. Pharmacol., 22, 179-188 (2008).
13. Riess M.-L., Stowe1 D.-F., Warltier D.-C., Am. J. Physiol. Heart Circ. Physiol., 286, H1603-H1607 (2004).
14. Yellon D.-M., Dana A., Circ. Res., 87, 543-550 (2000).
15. Schulz R., Post H., Vahlhaus C., Heusch G., Circulation, 98, 1022-1029 (1998).
16. Schulz R., Gres P., Heusch G., Am.J.Phys- iol. Heart Circ. Physiol., 280, H2175-H2181 (2001).
17. Miyawaki H., Ashraf M., Circ. Res., 80, 790-799 (1997).
18. Miyawaki H., Zhou X., Ashraf M., Circ. Res., 79, 137-146 (1996).
19. Pierre S.-V., Yang C., Yuan Z., Seminerio J., Mouas C., Garlid K.-D., Dos-Santos P., Xie Z., Cardiovasc. Res., 73, 488-496 (2007).
20. Hauptman P.-J., Kelly R.-A., Circulation, 99, 1265-1270 (1999).
21. Akera T., Brody T.-M., Pharmacol. Rev., 29, 187-220 (1977).
22. Krstic D., Tomic N., Krinulovic K., Vasic V., J. Enzyme Inhib. Med. Chem., 21(4), 471-475 (2006).
23. Himori N., Wantanabe H., Akaike N., Kurasawa M., ltoh J., Tanaka Y., J., Pharmacol. Meth., 23, 311-327 (1990).
24. Bochelen D., Rudin M., Sauter A., J. Pharmacol. Exp. Ther., 288, 653-659 (1999).
25. Gupta R., Singh M., Sharma A., Pharmacol. Res., 48(2), 209-215 (2003).
26. Itoh J., Nabeshima T., Kameyama T., Psychopharmacology, 101, 27-32 (1990).
27. Zdenek H., ivan K., Behav. Brain Res., 91, 83-89 (1998).
28. Dunham N.-W., Miya T.-S., J. Am. Pharm. Assoc. (Baltim) 46(3), 208-209 (1957).
29. Feeney D.-M., Boyeson M.-G., Linn R.-T., Murray H.-M., Dail W.-G., Brain Res., 211, 67-77 (1981).
30. Bederson J.-B., Pitts L.-H., Tsuji M., Nishimur M.-C., Davis R.-L., Bartowski H., Stroke, 17, 472-476 (1986).
31. Zhai P., Eurell T.-E., Cotthaus R., Jeffery E.-H., Bahr J.-M., Gross D.-R., Am. J. Physiol. Heart Circ. Physiol., 279, H2766-H2775 (2000).
32. Alonsode de Lecinana M., Diez-Tejedor E., Cearcellar F., Roda J.-M., Cerebrovasc. Dis., 11(1), 20-30 (2001).
33. Neumar R.-W., Annals. of Emergency Medicine, 36, 483-506 (2000).
34. Jenkins L.-W., Povlishock J.-T., Lewelt W., Miller J.-D., Becker D.-P., Acta Neuropathol., 5, 205-220 (1981).
35. Dobkin B.-H., Clin. Geriat. Med., 7, 507-523 (1991).
36. Wong A.-M., Hodges H., Horsburgh K., Brain Res., 1063, 140-150 (2005).
37. Wang S.-Q., Song L.-S., Lakatta E.-G., Cheng H., Nature, 410, 592-596 (2001).
38. Fabiato A., J. Gen. Physiol., 85, 247-289 (1985).
39. Mcgarry S.-J., Williams A.-J., Br. J. Pharmacol., 108, 1043-1050 (1993).
40. Budde T., Munsch T., Pape H.-C., Eur. J. Neurosci., 10(2), 586-597 (1998).
41. Finkbeiner S., Greenberg M.-E., J. Neurobiol., 37, 171-189 (1998).
42. Carafoli E., Santalla L., Branca D., Brini M., Crit. Rev. Biochem. Mol. Biol., 36, 107-260 (2001).
43. Bishnoi M., Chopra K., Kulkarni S.-K., Neu- rochem. Res., 33(9), 1869-1880 (2008).
44. Lashgari R., Motamedi F., Noorbakhsh S.-M., Zahedi-Asl S., Komaki A., Shahidi S., Haghparast A., Neurosci. Lett., 415(2), 174-178 (2007).
45. Ma Y.-Y., Huo H.-R., Li C.-H., Zhao B.-S., Li L.-F., Sui F., Guo S.-Y., Jiang T.-L., Biol. Pharm. Bull., 31, 426-430 (2008).
46. Marian T., Szabo-Peli J., Nemeth E., Tron L., Friedlander E., Szabo A., Balkay L., Veress G., Krasznai Z., Eur. J. Pharm. Sci., 30(1), 56-63 (2007).